Skip to Content

Janus Henderson Global Life Sciences A JFNAX

Quantitative rating as of
NAV / 1-Day Return
66.31  /  0.73 %
Total Assets
4.8 Bil
Adj. Expense Ratio
0.970%
Expense Ratio
0.970%
Distribution Fee Level
Low
Share Class Type
Front Load
Category
Health
Investment Style
Large Blend
Min. Initial Investment
2,500
Status
Open
TTM Yield
1.05%
Turnover
32%

Morningstar’s Analysis JFNAX

Will JFNAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

Janus Henderson Global Life Sciences A’s management team is just average, but a solid investment process still helps this strategy retain its Morningstar Quantitative Rating of Bronze. The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Unlock our full analysis with Morningstar Investor